Imaxe de Portada

Development in wastewater treatment research and processes : innovative trends in removal of refractory pollutants from pharmaceutical wastewater /

Development in Wastewater Treatment Research and Processes: Innovative Trends in Removal of Refractory Pollutants from Pharmaceutical Waste Water sorts out emerging and burning issues faced by the pharmaceutical industry, along with common effluent treatment plans.

Gardado en:
Detalles Bibliográficos
Outros autores: Rodriguez-Couto, Susana, Shah, Maulin P.
Formato: eBook
Idioma:inglés
Publicado: Amsterdam : Elsevier, 2024.
Subjects:
Sewage > Purification.
Pharmaceutical industry > Environmental aspects.
Refractory materials > Environmental aspects.
Eaux usées > Épuration.
Industrie pharmaceutique > Aspect de l'environnement.
Matériaux réfractaires > Aspect de l'environnement.
Pharmaceutical industry > Environmental aspects
Sewage > Purification
Acceso en liña:ScienceDirect
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
Table of Contents:
  • Front Cover
  • Development in Wastewater Treatment Research and Processes
  • Development in Wastewater Treatment Research and Processes
  • Contents
  • Contributors
  • 1
  • Pharmaceutical wastewater management: Physicochemical, chemical, and biological approaches
  • 1. Introduction
  • 2. Pharmaceutical compounds present in the wastewater
  • 3. Physicochemical approach for the elimination of emerging contaminants
  • 3.1 Coagulative precipitation
  • 3.2 Electrocoagulation
  • 3.3 Sedimentation
  • 3.4 Floatation
  • 3.5 Electrolysis
  • 3.6 Adsorption
  • 3.7 Membrane separation
  • 4. Chemical approach for removing emerging contaminants
  • 4.1 Advanced oxidation
  • 4.2 Wet air oxidation (WAO)
  • 4.3 Supercritical water oxidation (SCWO)
  • 4.4 Electro-fenton reagent
  • 4.5 Biological electro fenton (Bio-EF)
  • 4.6 Photocatalytic oxidation
  • 4.7 Ultrasound oxidation (UAO)
  • 4.8 Electrochemical oxidation
  • 4.9 Ozonation
  • 4.10 Perozonation
  • 4.11 Iron-carbon method
  • 4.12 Chlorination
  • 4.13 Flocculation
  • 5. Biological treatment approach for the removal of emerging contaminants
  • 5.1 Activated sludge process (ASP)
  • 5.2 Sequence batch reactor (SBR)
  • 5.3 Moving bed biofilm reactor (MBBR)
  • 5.4 Membrane bioreactor (MBR)
  • 5.5 Trickling filter (TF)
  • 5.6 Anaerobic treatment system
  • 5.6.1 Hybrid anaerobic+biological system
  • 5.6.2 Hybrid anaerobic+chemical/physical systems
  • 5.7 Hybrid biological-physical- treatment processes
  • 5.8 Hybrid biological-physical-chemical treatment processes
  • 6. Phyto-remediation approaches for pharmaceuticals wastewater treatment
  • 7. Mycoremediation approaches for pharmaceuticals wastewater treatment
  • 8. Phyco-remediation approaches for pharmaceutical wastewater treatment
  • 9. Pharmaceuticals wastewater treatment during the COVID-19 pandemic.
  • 10. Clustered regularly interspaced palindromic repeats (CRISPR) assisted bioremediation approach
  • 11. Conclusion
  • References
  • 2
  • Applications of ultrafiltration, nanofiltration, and reverse osmosis in pharmaceutical wastewater treatment
  • 1. Introduction
  • 2. Membrane separation approaches
  • 3. Removal of emerging pharmaceutical contaminants by nanofiltration membrane system
  • 4. Removal of the emerging pharmaceutical contaminants by ultrafiltration membrane system
  • 5. Removal of emerging contaminants by reverse osmosis membrane system
  • 6. Conclusion
  • References
  • 3
  • Recent advancement in bioremediation of pharmaceutical wastewater
  • 1. Introduction
  • 2. Refractory pollutants
  • 3. Pharmaceutical industry wastewater (PIWW)
  • 4. Bioremediation
  • 4.1 Bioadsorption
  • 4.2 Bioaccumulation
  • 4.3 Biodegradation
  • 4.4 Photo-biodegradation
  • 4.5 Volatilization
  • 5. Microorganisms involved in bioremediation of PIWW
  • 5.1 Bacterial bioremediation
  • 5.2 Fungal bioremediation
  • 5.3 Phycoremediation
  • 5.4 Phytoremediation
  • 6. Membrane bioreactors
  • 7. Enzyme-driven bioremediation
  • 8. Future perspective of bioremediation in PIWW treatment
  • 9. Conclusions
  • References
  • 4
  • Hybrid membrane processes equipped with crystallization unit for a simultaneous recovery of freshwater and mine ...
  • 1. Introduction
  • 2. Principles of membrane crystallization
  • 2.1 Module configurations in membrane distillation crystallization
  • 2.1.1 DCMD
  • 2.1.2 AGMD
  • 2.1.3 VMD
  • 2.1.4 SGMD
  • 2.2 Process of crystallization and precipitation
  • 2.3 Factors affecting crystallization
  • 2.3.1 Temperature
  • 2.3.2 Flowrate
  • 2.3.3 Concentration of the feed solution
  • 3. Membranes used in membrane crystallization
  • 4. Fouling and wetting in membrane crystallization
  • 5. Fouling and wetting mitigation strategies
  • 5.1 Membrane modification.
  • 5.2 Membrane cleaning
  • 5.3 Pre-treatment processes
  • 6. Application of membrane crystallization for the treatment of wastewater
  • 7. Conclusion
  • References
  • 5
  • Advanced (nano)materials
  • 1. Introduction
  • 2. Green nanotechnology
  • 3. Green nanomaterial preparation
  • 3.1 Physical method
  • 4. Chemical method
  • 5. Biological method
  • 6. Biosynthesis of NPs using microorganisms
  • 6.1 Synthesis of nanoparticles using fungi
  • 7. Synthesis of nanoparticles using yeast
  • 8. Synthesis of nanoparticles using bacteria
  • 9. Synthesis of nanoparticles using actinomycetes
  • 10. Synthesis of nanoparticles using plant
  • 11. Applications of green nanomaterials
  • 12. Environmental cleanup
  • 13. Nanoremediation
  • 14. Nanomaterials as adsorbents for water treatment
  • 15. Nanomaterials in photocatalysis
  • 16. Copper oxide in photocatalysis
  • 17. Nanosized iron oxides
  • 18. Magnesium oxide NPs (MgO-NPs)
  • 19. Nanocomposites in water treatment
  • 20. Nanocomposite membrane
  • 21. Magnetic nanocomposites
  • 22. Chitosan NPs
  • 23. Cellulose based nanoadsorbent
  • 24. Dendrimer nanoadsorbent
  • 25. Major problems in photocatalysis processes
  • 26. Reusability of nanocomposites
  • 27. Disinfection
  • 28. Conclusion
  • References
  • 6
  • Removal of pharmaceutical contaminants from wastewater using activated sludge process
  • 1. Introduction
  • 1.1 Pharmaceutical manufacturing industries
  • 1.2 Human and animal excretions
  • 1.3 Hospital and clinic effluents
  • 2. Major units of activated sludge process based wastewater treatment
  • 2.1 Screening
  • 2.2 Grit chamber
  • 2.3 Primary settling tank
  • 2.4 Aeration tank
  • 2.5 Secondary clarifier
  • 3. Removal of pharmaceutical contaminants by activated sludge process
  • 3.1 Hydraulic retention time (HRT)
  • 3.2 Sludge retention time (SRT)
  • 3.3 Redox conditions and temperature.
  • 4. Removal process in ASP for pharmaceuticals
  • 4.1 Biodegradation
  • 4.2 Sorption
  • 5. Techniques to enhance elimination of pharmaceutical in ASP
  • 5.1 Activated carbon insertion
  • 5.2 Hybridization with ASP
  • 6. Conclusion
  • References
  • 7
  • Bacteria mediated cadmium removal for wastewater treatment
  • 1. Introduction
  • 2. Cadmium toxicity
  • 3. Conventional methods of cadmium removal
  • 4. Bacteria mediated cadmium removal
  • 5. Conclusions and future perspectives
  • References
  • 8
  • Oxidation and advanced oxidation processes in pharmaceutical wastewater treatment
  • 1. Introduction
  • 2. Organic contaminants in waste water
  • 3. Oxidation processes
  • 4. Advance oxidation processes
  • 5. Principle and types of AOP
  • 6. Mechanism of AOPs
  • 7. Advanced AOPs catalyzed by hydrogen peroxide
  • 8. AOPs using UV radiation
  • 9. Strategies for efficient optimization of AOPs
  • 10. Merits of AOPs
  • 11. Limitations of AOPs
  • 12. Studies on AOPs for waste water treatment
  • 13. Conclusion and future trend
  • References
  • 9
  • Nanomaterials for the removal of pollutants from pharmaceutical wastewater
  • 1. Introduction
  • 2. Physio-chemical properties of pharmaceutical pollutants
  • 3. Toxicological impact of pharmaceutical pollutants on ecosystem
  • 4. Synthesis techniques of nanostructure materials
  • 4.1 Chemical vapor deposition
  • 4.2 Ball milling
  • 4.3 Pyrolysis
  • 4.4 Hydrothermal carbonization
  • 4.5 Exfoliation
  • 5. Mechanism behind the removal of contaminates by nanomaterials
  • 6. Application of nanomaterials for the removal of pharmaceuticals
  • 6.1 Carbon based nanomaterials
  • 6.1.1 Carbon nanotubes
  • 6.1.2 GO based nanomaterials
  • 6.1.3 RGO based nanomaterials
  • 6.2 Metal-based nanomaterials
  • 7. Limitations
  • 8. Conclusion and prospects
  • References.
  • 10
  • Bio nanotechnology: An emerging tools to remove refractory pollutant from pharmaceutical wastewater
  • 1. Introduction
  • 2. Methods for treatment of pharmaceutical waste water
  • 3. Nanotechnology
  • 4. Synthesis of nanoparticles
  • 4.1 Nanoparticles produced by plants
  • 5. Bacteria-generated nanoparticles
  • 6. Yeast and fungal nanoparticles
  • 7. Nanotechnology for bioremediation
  • 8. Different nanomaterials and treatment of pharmaceutical waste water
  • 9. Nanofilter membrane bioreactor
  • 10. Nanoadsorbants
  • 11. Nanocatalyst
  • 12. Conclusion
  • References
  • 11
  • Bioremediation of pharmaceutical contaminants from wastewater by mushrooms
  • 1. Introduction
  • 2. Pharmaceutical residues
  • 3. Wastewater treatment
  • 4. Mushrooms in bioremediation of pharmaceutical contaminants from wastewater
  • 4.1 Pleurotus sp.
  • 4.2 Trametes versicolor
  • 4.3 Phanerochaete chrysosporium
  • 4.4 Agaricus bisporus and Lentinula edodes
  • 5. Perspectives and conclusions
  • References
  • 12
  • Microbial bioremediation potentials for refractory pollutants removal from pharmaceutical wastewater
  • 1. Introduction
  • 2. Nature and origin of pharmaceutical wastes
  • 3. Bioremediation in treatment of pharmaceutical wastes
  • 3.1 Bacteria and actinomycetes in bioremediation
  • 3.2 Ultrafiltration membrane biological reactor based on nitrifying bacteria
  • 3.3 Fungal bioremediation
  • 3.4 Microalgal bioremediation (phycoremediation)
  • 3.5 Technologies used to improve microbial bioremediation
  • 4. Future prospects and conclusion
  • References
  • 13
  • Innovative technologies for emerging issues in pharmaceuticals
  • 1. Introduction
  • 2. State of the art on the occurrence of pharmaceuticals all over the world
  • 3. New emerging technologies for the removal of pharmaceuticals from the environment.

Títulos similares